Table 2.
Results
| Results | Patients (n = 79) |
|---|---|
| LVEF end WCD wear, % (median, IQR) | 37.5 (23.5–45.8) |
| Number of days WCD wear (median, IQR) | 79.0 (50.0–109.8) |
| Average hours WCD wear a day (median, IQR) | 23.3 (22.6–23.7) |
| Appropriate therapy (n, %) | 2 (2.6%) |
| Inappropriate therapy (n, %) | 1 (1.3%) |
| Aborted therapy (n, %) | 48 (63.2%) |
|
ICD implantation
One chamber TV-ICD Dual chamber TV-ICD S-ICD CRT-D |
45 (57.0%)
7 (15.6%) 13 (28.9%) 8 (17.8%) 17 (37.7%) |
| Patients with recovered LVEF after WCD (n, %) | 24 (30.4%) |
|
Patients with ICD indication that were not implanted (n, %)
Patient refused ICD Patient deceased before implantation Patient was implanted with LVAD |
8 (10.1%)
3 (37.5%) 4 (50%) 1 (12.5%) |
| Hospitalisation days prevented in ‘bridge-to-implantation’ patients (median, IQR) | 79.0 (54.8–102.3) |
IQR interquartile range, LVEF left ventricular ejection fraction, S-ICD subcutaneous implantable cardioverter-defibrillator, TV-ICD transvenous implantable cardioverter-defibrillator, WCD wearable cardioverter-defibrillator